Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 Effects of In Vivo and In Vitro Nitroglycerin Treatment on Vascular ALDH Activity in Human Bypass Vessels
In vivo nitroglycerin (GTN) treatment, in vitro GTN, as well as the use of benomyl markedly inhibited aldehyde dehydrogenase (ALDH) activity in both A. mammaria (left panel) and V. saphena (right panel). n = number of patients/vessel segments/group as shown. *p < 0.05 versus without GTN pretreatment (CTR);  p < 0.05 between vessel types.
|
